Lucknow (UP): There will be relief for patients suffering from axial spondylarthritis (AS) as positive developments in the form of biologic drugs have made it possible to reverse effects of the condition to a significant extent and improve their overall quality of life. Axial spondylarthritis is a type of arthritis that commonly affects the chest, spine and pelvis, mostly in the 16-45 age group.
Experts at King George’s Medical University (KGMU) said that patients can now receive more effective treatment options to manage their pain. Prof K K Sawlani of medicine department, KGMU, stated that the AS is the most common form of spondylarthritis, which is characterized by spine inflammation.
AS prevalence ranges from nine to 30 per 10,000 in the general population according to recent studies. “Traditionally, people believe that patients should exercise and take pain killers as they are the only options. But different biological drugs have shown improvement and reversal to great extent,” he added.